Professor Nina Gocheva dropped a bomb on COVID-19 remodeling, blood plasma and mortality



[ad_1]

Remdesivir reduces hospital stays and has nothing to do with mortality. It is not a harmless medicine. It is applied individually according to the particularities of each patient. Nor has blood plasma been shown to be effective in terms of mortality. Plasma is not useful in intubated patients. This is what the cardiologist Prof. Nina Gocheva said in “Offensive with Lubo Ognyanov” on Channel 3.

He noted that there was no causal link between coronavirus infection and pacemaker function, as was the case with coronary heart disease. She insisted that prophylactic aspirin and other antiplatelet drugs should not be taken prophylactically. These medications are not recommended for mild covid.

Azithromycin occurs in moderate to severe COVID cases.
Professor Gocheva was another specialist who warned that the chaotic use of antibiotics can generate resistance. “So it would be really scary. ”

According to her, the measures announced at this time are completely sufficient.

The coronavirus damage to the heart is being studied, the specialist said. If you have a history of cardiovascular disease, a complication can occur. It is true that this virus can cause myocarditis. Another common complication is pulmonary embolism. That would be a fatal situation. Thrombosis is seen at the level of the microcirculation, explained Professor Gocheva.



[ad_2]